# Which UK funds hold DexCom, Inc. (DXCM)?

**Source:** https://fundology.uk/stock/DXCM · NASDAQ: DXCM · Data: fund issuers' published holdings (dates differ by fund; newest 02/10/2026), company profile by TradingView

DexCom, Inc. (DXCM) is among the ten largest holdings of 2 UK funds Fundology covers, according to the holdings each fund publishes. In the largest of these funds by size, it makes up 5.24% of CURG (VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD) and 7.50% of CYBG (VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD). The largest weight is 7.50%, in CYBG (VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD), as of 02/10/2026. In all, 244 funds list it among their published holdings.

## Funds where DexCom, Inc. is one of the ten largest holdings

2 funds, largest weight first. A weight is the share of the fund's money in this company, as of the date of that fund's published holdings.

| Fund | Ticker | ISIN | Weight in the fund | Holdings as of |
|---|---|---|---|---|
| [VanEck Medical Robotics and Bionic Engineering UCITS ETF Accum A USD](https://fundology.uk/fund/cybg) | CYBG | IE0005TF96I9 | 7.50% | 02/10/2026 |
| [VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD](https://fundology.uk/fund/curg) | CURG | IE000B9PQW54 | 5.24% | 02/10/2026 |

242 more funds list DexCom, Inc. below their ten largest holdings. Each fund page shows its ten largest holdings to everyone; the full lists need a free account.

Holdings come from the issuers that publish them. Some publish only their ten largest positions, so a fund can hold this company without appearing here. Index funds hold companies roughly in proportion to their size in the index, so the largest companies appear in many funds at similar weights.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.